Many people think shingles—a viral infection that causes a painful rash—is something only older people deal with, given that the risk generally increases with age. But Jacquelyn Gill, a professor at ...
The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia. Shingles, caused by the ...
Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...
BANGALORE, Dec 13 (Reuters) - U.S. biotechnology company Inhibitex Inc's experimental drug to treat shingles failed to meet the main goal of a mid-stage trial, sending its shares down 17 percent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback